Intra-articular Pulsed Radiofrequency With Steroids Injection Versus Intra-articular Steroids Injection in Chronic Sacroiliac Joint Arthritis
- Conditions
- Pain Management
- Interventions
- Registration Number
- NCT03564106
- Lead Sponsor
- Assiut University
- Brief Summary
The sacroiliac joint is Located between the pelvis and base of the spine, the sacroiliac joints are strong, stable joints that allow for little movement. While these joints do not bend like a knuckle or knee, they are susceptible to degenerative arthritis. Sacroiliac joint pain is one of the most common causes of chronic low back pain, accounting for 10% to 27% of patients with chronic lower back pain. It is known to be caused by abnormal motion in this joint, namely, too much motion or too little motion. Patients with pain experience various degrees of pain in the low back, groin, buttock, or posterior thigh.
- Detailed Description
The pain starts when the Sacroiliac joint gets inflamed. There are several reasons it could happen. It could be hurt when playing sports or if fall down.
Sometimes start hurting when the ligaments that hold the SI joint together are damaged, which may make the joint move abnormally. The pain associated with sacroiliitis most commonly occurs in the buttocks and lower back. It can also affect the legs, groin and even the feet.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- All patients must have chronic pain more than 6 months and have failed medical treatment.
- Infection at the site of injection
- Opioids addiction
- Coagulopathy or another bleeding diathesis
- Those who refuse to participate in the study
- Ankylosing Spondylitis patients
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description group A intraarticular radiofrequency + intraarticular methylprednisolone receive intraarticular radiofrequency + methylprednisolone (30 mg) group C intraarticular methylprednisolone receive intraarticular methylprednisolone (30 mg)
- Primary Outcome Measures
Name Time Method pain intensity up to 6 months Numeric Rating Scale (NRS)
- Secondary Outcome Measures
Name Time Method Patient Impression up to 6 months Patient Global Impression of Change Scale (PGIC)
Pain Disability up to 6 months Pain Disability Index ( PDI)
Trial Locations
- Locations (1)
Assiut governorate
🇪🇬Assiut, Egypt